JNJ

J&J takes $630M hit on RSV drug bought with Alios
J&J takes $630M hit on RSV drug bought with Alios
Fierce Biotech
JNJ
RSV
Alios BioPharma
AL-8176
lumicitabine
Flag link:
2 Big Pharmas Pleased With J&J's Third-Quarter Earnings Report
2 Big Pharmas Pleased With J&J's Third-Quarter Earnings Report
Motley Fool
JNJ
earnings
Pfizer
Merck
Flag link:
J&J stalls development of antiviral from Alios deal
J&J stalls development of antiviral from Alios deal
BioCentury
JNJ
antivirals
Alios BioPharma
AL-8176
lumicitabine
Flag link:
Prescription drugs, lower taxes, power J&J 3Q beat
Prescription drugs, lower taxes, power J&J 3Q beat
Yahoo/AP
JNJ
earnings
Flag link:
J&J posts softer Q3 device sales
J&J posts softer Q3 device sales
MedTech Dive
JNJ
earnings
devices
Flag link:
UnitedHealthcare gives Remicade biosims a leg up with changes to Medicare plans
UnitedHealthcare gives Remicade biosims a leg up with changes to Medicare plans
Fierce Pharma
CMS
UnitedHealthcare
Medicare
JNJ
Remicade
biosimilars
Pfizer
Merck
Flag link:
J&J snaps up key label expansion for Xarelto
J&J snaps up key label expansion for Xarelto
Biopharma Dive
JNJ
Xarelto
bloodthinners
Eliquis
Janssen
Bayer
Flag link:
3 Big Pharma Stocks Racing Along the Road to China
3 Big Pharma Stocks Racing Along the Road to China
Motley Fool
China
cancer
Pfizer
AstraZeneca
JNJ
Flag link:
J&J's Stelara succeeds in chronic bowel disease study
J&J's Stelara succeeds in chronic bowel disease study
Yahoo/Reuters
JNJ
Stelara
ulcerative colitis
Flag link:
See, snap and fund: Johnson & Johnson Vision push for eye health to donate to charity for shared photos
See, snap and fund: Johnson & Johnson Vision push for eye health to donate to charity for shared photos
Fierce Pharma
JNJ
eye health
JNJ Vision
social media
Flag link:
Johnson & Johnson pays $175M, commits to $1.6B in milestones for Arrowhead hepatitis B drug
Johnson & Johnson pays $175M, commits to $1.6B in milestones for Arrowhead hepatitis B drug
Fierce Biotech
JNJ
Arrowhead
hepatitis B
RNAi
Flag link:
Johnson & Johnson Bets on Nurses in Push to Develop Innovative Medical Devices
Johnson & Johnson Bets on Nurses in Push to Develop Innovative Medical Devices
Xtalks
JNJ
devices
JLabs
nurses
innovation
Flag link:
Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?
Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?
Motley Fool
Geron
JNJ
Flag link:
J&J inks collab deal to develop MERS vaccine
J&J inks collab deal to develop MERS vaccine
Drug Delivery Business News
JNJ
MERS
vaccines
Flag link:
J&J has decided — pharma giant dumps its development deal on Geron’s imetelstat, shattering shares
J&J has decided — pharma giant dumps its development deal on Geron’s imetelstat, shattering shares
Endpoints
JNJ
Geron
imetelstat
Flag link:
J&J's Esketamine Fails to Meet Endpoint in Phase III Study
J&J's Esketamine Fails to Meet Endpoint in Phase III Study
Yahoo/Zacks.com
JNJ
clinical trials
esketamine
treatment-resistant depression
Flag link:
Boston Scientific, Edwards Lifesciences May Tempt J&J
Boston Scientific, Edwards Lifesciences May Tempt J&J
Barrons
devices
JNJ
Boston Scientific
Edwards Lifesciences
Flag link:
Pfizer, Merck and Johnson & Johnson shifting profits to avoid billions in tax payments each year: report
Pfizer, Merck and Johnson & Johnson shifting profits to avoid billions in tax payments each year: report
Fierce Pharma
taxes
Pfizer
Merck
JNJ
Abbott Labs
Flag link:
J&J Files NDA for Erdafitinib in Urothelial Cancer Indication
J&J Files NDA for Erdafitinib in Urothelial Cancer Indication
Yahoo/Zacks.com
JNJ
erdafitinib
urothelial cancer
Flag link:
Pharma/Biotech Stocks to Watch This Prostate Cancer Month
Pharma/Biotech Stocks to Watch This Prostate Cancer Month
Yahoo/Zacks.com
prostate cancer
JNJ
Zytiga
Erleada
Pfizer
Astellas
Xtandi
AbbVie
Lupron
Endocyte
Lu-PSMA-617
Flag link:

Pages